603
Participants
Start Date
March 31, 2014
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
APD356-lorcaserin hydrochloride
Placebo
Integrative Clinical Trials, Brooklyn
Clinical Trial Center, Jenkintown
PMG Research Inc., Winston-Salem
PMG Research Inc., Raleigh
Duke University, Durham
PMG Research Inc., Wilmington
Coastal Carolina Research Center, Mt. Pleasant
iResearch Atlanta, Decatur
Clinical Neuroscience Solutions, Inc., Jacksonville
Avail Clinical Research, DeLand
Compass Research East, Oviedo
Clinical Neuroscience Solutions, Inc., Orlando
Compass Research, Orlando
Meridien Research, Tampa
Meridien Research, Lakeland
Compass Research East, Leesburg
Clinical Research Associates, Inc., Nashville
Clinical Neuroscience Solutions, Inc., Memphis
Neurobehavioral Clinical Research, Canton
Midwest Clinical Research Center, Dayton
Center for Pharmaceutical Research, Kansas City
Quality Clinical Research Inc., Omaha
KRK Medical Research, Dallas
Benchmark Research, Austin
Clinical Research Center of Nevada, Las Vegas
Pharmacology Research Institute, Los Alamitos
Pharmacology Research Institute, Encino
Synergy Escondido, Escondido
Desert Valley Research, Rancho Mirage
Pharmacology Research Institute, Newport Beach
Lincoln Research, Lincoln
Lead Sponsor
Arena Pharmaceuticals
INDUSTRY